References
- Michael, A. F. and Christopher, T. W. : Antibiotics for emerging pathogens. Science 325, 1089 (2009). https://doi.org/10.1126/science.1176667
- Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilber, D., Rice, L. B., Scheld, M., Spellberg, B. and Bartlett, J. : Bad bugs, no drugs : no ESKAPE! An update from the infectious diseases society of America. Clin. Infect. Dis. 48, 1 (2009). https://doi.org/10.1086/595011
- Rybak, J. M., Barber, K. E. and Rybak, M. J. : Current and prospective treatments for multidrug-resistant gram-positive infections. Expert Opin Pharmacother. 14, 1919 (2013). https://doi.org/10.1517/14656566.2013.820276
- O'Connell, K. M., Hodgkinson, J. T., Sore, H. F., Welch, M., Salmond, G. P. and Spring, D. R. : Combating multidrugresistant bacteria: Current strategies for the discovery of novel antibacterials. Angew. Chem. Int. Ed. Engl. 41, 10706 (2013).
- Pucci, M. J. and Bush, K. : Investigational antimicrobial agents of 2013. Clin. Microbiol. Rev. 26, 792 (2013). https://doi.org/10.1128/CMR.00033-13
- Perry, C. M. and Jarvis, B. : Linezolid: a review of its use in the management of serious Gram-positive infections. Drugs 61, 525 (2001). https://doi.org/10.2165/00003495-200161040-00008
- Flamm, R. K., Mendes, R. E., Ross, J. E., Sader, H. S. and Jones, R. N. : Linezolid surveillance results for the united states: LEADER surveillance program 2011. Antimicrob. Agents Chemother. 57, 1077 (2013). https://doi.org/10.1128/AAC.02112-12
- Gill, C. J., Abruzzo, G. K., Flattery, A. M., Misura, A. S., Bartizal, K. and Hickey, E. J. : In vivo efficacy of a novel oxazolidinone compound in two mouse models of infection. Antimicrob. Agents Chemother. 51, 3434 (2007). https://doi.org/10.1128/AAC.01567-06
- Leach, K. L., Swaney, S. M., Colca, J. R., McDonald, W. G., Blinn, J. R., Thomasco, L. M., Gadwood, R. C., Shinabarger, D., Siong, L. and Mankin, A. S. : The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria. Mol. Cell. 26, 393 (2007). https://doi.org/10.1016/j.molcel.2007.04.005
- Bing, G., Theodoros, K., Sotirios, T., Janet, H. and Romney, M. H. : The emerging problem of linezolid-resistant Staphylococcus. J. Antimicrob. Chemother. 68, 4 (2013). https://doi.org/10.1093/jac/dks354
- Meka, V. G. and Gold, H. S. : Antimicrobial resistance to linezolid. Clin. Infect. Dis. 39, 1010 (2004). https://doi.org/10.1086/423841
- Cattaneo, D., Orlando, G., Cozzi, V., Cordier, L., Baldelli, S., Merli, S., Fucile, S., Gulisano, C., Rizzardini, G. and Clementi, E. : Linezolid plasma concentrations and occurrence of drugrelated haematological toxicity in patients with gram-positive infections. Int. J. Antimicrob. Agents. 41, 586 (2013). https://doi.org/10.1016/j.ijantimicag.2013.02.020
- Nukui, Y., Hatakeyama, S., Okamoto, K., Yamamoto, T., Hisaka, A., Suzuki, H., Yata, N., Yotsuyanagi, H. and Moriya, K. : High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia. J. Antimicrob. Chemother. 68, 2128 (2013). https://doi.org/10.1093/jac/dkt133
- Jeong, J. W., Jung, S. J., Lee, H. H., Kim, Y. Z., Park, T. K., Cho, Y. L., Chae, S. E., Baek, S. Y., Woo, S. H., Lee, H. S. and Kwak, J. H. : In vitro and in vivo activities of LCB01-0371, a new oxazolidinone. Antimicrob. Agents Chemother. 54, 5359 (2010). https://doi.org/10.1128/AAC.00723-10
- Jones, R. N., Moet, G. J., Sader, H. S., Mendes, R. E. and Castanheira, M. : TR-700 in vitro activity against and resistance mutation frequencies among Gram-positive pathogens. J. Antimicrob. Chemother. 63, 716 (2009). https://doi.org/10.1093/jac/dkp021
- Prystowsky, J., Siddiqui, F., Chosay, J., Shinabarger, D. L., Millichap, J., Peterson, L. R. and Noskin, G. A. : Resistance to linezolid : characterization of mutations in rRNA and comparison of their occurrences. Antimicrob. Agents Chemother. 45, 2154 (2001). https://doi.org/10.1128/AAC.45.7.2154-2156.2001
- Samir, N. P., Nader, M., Dea, S., Baldwin, T., Frances, B. J. and David, J. F. : Linezolid resistance in Enterococcus faecium isolated in Ontario, Canada. Diagn. Microbiol. Infect. Dis. 77, 350 (2013). https://doi.org/10.1016/j.diagmicrobio.2013.08.012
- Lobritz, M., Hutton-Thomas, R., Marshall, S. and Rice, L. B. : Recombination proficiency influences frequency and locus of mutational resistance to linezolid in Enterococcus faecalis. Antimicrob. Agents Chemother. 47, 3318 (2003). https://doi.org/10.1128/AAC.47.10.3318-3320.2003